News Center
Lizhu was selected for the 2022 Top 20 ESG Competitiveness of Chinese Pharmaceutical Listed Companies and the Top 10 Wind ESG Rating Industry List.
Release time:
2022-11-28
Recently, the ESG competitiveness ranking of Chinese pharmaceutical listed companies was released, and Livzon was selected for the "2022 Top 20 ESG Competitiveness of Chinese Pharmaceutical Listed Companies" list due to its outstanding performance in ESG transparency and ESG management performance, ranking first.
This ranking is based on the ESG reports publicly released by listed companies, evaluating a sample of about 150 A-share and Hong Kong-listed companies in the Chinese pharmaceutical industry that meet the criteria, selecting the "2022 Top 20 ESG Competitiveness of Chinese Pharmaceutical Listed Companies" based on the two core dimensions of "ESG Transparency Evaluation" and "ESG Management Performance Evaluation."
Additionally, Livzon has been rated AA by Wind ESG and was recently included in the Top 10 of the healthcare industry in the "2022 Wind China A-share Listed Companies ESG Rating List," and also included in the Top 10 of the healthcare industry in the "2022 Wind Hong Kong Listed Companies ESG Rating List."
Wind launched the Wind ESG rating in 2021, combining its twenty years of data processing and analysis experience, domestic and international ESG standards, and unique insights into Chinese ESG investment. The Wind ESG rating has integrated international standards and guidelines such as ISO 26000, SDGs, GRI Standards, SASB, TCFD, while also considering the policies and current situation of ESG information disclosure for Chinese companies. This year, the rating has covered all A-share and Hong Kong-listed companies.
The above honors represent the industry's and society's recognition of Livzon's comprehensive ESG competitiveness in the pharmaceutical industry. In the future, Livzon will continue to uphold the mission of "Patient Quality of Life First," support the Healthy China strategy, seek health and well-being for more patients, practice a green development path, promote the harmonious development of enterprises, employees, society, and the environment, and create long-term sustainable value for the company and its partners.
Related Information